Carbazole-, Aspidofractinine-, and Aspidocarpamine-Type Alkaloids from Pleiocarpa pycnantha

Three new alkaloids, janetinine (1a), pleiokomenine A (2), and huncaniterine B (3a), and 13 known compounds, pleiomutinine (3b), huncaniterine A (3c), 1-carbomethoxy-β-carboline (4), evoxanthine (5), deformyltalbotine acid lactone (6), pleiocarpamine (7), N4-methyl-10-hydroxygeissoschizol (8), spegatrine (9), neosarpagine (10), aspidofractinine (11), N1-methylkopsinin (12), pleiocarpine (13), and N1-methylkopsinin- N4-oxide (14), were isolated from the stem bark of Pleiocarpa pycnantha. Janetinine (1a) is a carbazole alkaloid; in pleiokomenine A (2), two aspidofractinine-type alkaloids are bridged by a methylene unit in an unprecedented way, and huncaniterine B (3a) is a pleiocarpamine-aspidofractinine-type dimer. The structures and relative configurations of these compounds were elucidated on the basis of NMR and MS analyses. Their absolute configurations were defined by means of experimental and calculated ECD data, and additionally, the structures of 5 and 13 were determined by single crystal X-ray diffraction. Compounds 1a, 2, 3b, 4, 6, 9, and 12 displayed cancer chemopreventive properties through either quinone reductase induction ( CD = 30.7, 30.2, 29.9, 43.5, and 36.7 μM for 1a, 4, 6, 9, and 12, respectively) and/or NF-κB inhibition with IC50 values of 13.1, 8.4, 9.4, and 8.8 μM for 2, 3b, 6, and 12, respectively

Carbazole-, Aspidofractinine-, and Aspidocarpamine-Type Alkaloids from <i>Pleiocarpa pycnantha</i>

Three new alkaloids, janetinine (<b>1a</b>), pleiokomenine A (<b>2</b>), and huncaniterine B (<b>3a</b>), and 13 known compounds, pleiomutinine (<b>3b</b>), huncaniterine A (<b>3c</b>), 1-carbomethoxy-β-carboline (<b>4</b>), evoxanthine (<b>5</b>), deformyltalbotine acid lactone (<b>6</b>), pleiocarpamine (<b>7</b>), <i>N</i>⁴-methyl-10-hydroxygeissoschizol (<b>8</b>), spegatrine (<b>9</b>), neosarpagine (<b>10</b>), aspidofractinine (<b>11</b>), <i>N</i>¹-methylkopsinin (<b>12</b>), pleiocarpine (<b>13</b>), and <i>N</i>¹-methylkopsinin-<i>N</i>⁴-oxide (<b>14</b>), were isolated from the stem bark of <i>Pleiocarpa pycnantha</i>. Janetinine (<b>1a</b>) is a carbazole alkaloid; in pleiokomenine A (<b>2</b>), two aspidofractinine-type alkaloids are bridged by a methylene unit in an unprecedented way, and huncaniterine B (<b>3a</b>) is a pleiocarpamine–aspidofractinine-type dimer. The structures and relative configurations of these compounds were elucidated on the basis of NMR and MS analyses. Their absolute configurations were defined by means of experimental and calculated ECD data, and additionally, the structures of <b>5</b> and <b>13</b> were determined by single crystal X-ray diffraction. Compounds <b>1a</b>, <b>2</b>, <b>3b</b>, <b>4</b>, <b>6</b>, <b>9</b>, and <b>12</b> displayed cancer chemopreventive properties through either quinone reductase induction (<i>CD</i> = 30.7, 30.2, 29.9, 43.5, and 36.7 μM for <b>1a</b>, <b>4</b>, <b>6</b>, <b>9</b>, and <b>12</b>, respectively) and/or NF-κB inhibition with IC₅₀ values of 13.1, 8.4, 9.4, and 8.8 μM for <b>2</b>, <b>3b</b>, <b>6</b>, and <b>12</b>, respectively

Carbazole-, Aspidofractinine-, and Aspidocarpamine-Type Alkaloids from <i>Pleiocarpa pycnantha</i>

Three new alkaloids, janetinine (<b>1a</b>), pleiokomenine A (<b>2</b>), and huncaniterine B (<b>3a</b>), and 13 known compounds, pleiomutinine (<b>3b</b>), huncaniterine A (<b>3c</b>), 1-carbomethoxy-β-carboline (<b>4</b>), evoxanthine (<b>5</b>), deformyltalbotine acid lactone (<b>6</b>), pleiocarpamine (<b>7</b>), <i>N</i>⁴-methyl-10-hydroxygeissoschizol (<b>8</b>), spegatrine (<b>9</b>), neosarpagine (<b>10</b>), aspidofractinine (<b>11</b>), <i>N</i>¹-methylkopsinin (<b>12</b>), pleiocarpine (<b>13</b>), and <i>N</i>¹-methylkopsinin-<i>N</i>⁴-oxide (<b>14</b>), were isolated from the stem bark of <i>Pleiocarpa pycnantha</i>. Janetinine (<b>1a</b>) is a carbazole alkaloid; in pleiokomenine A (<b>2</b>), two aspidofractinine-type alkaloids are bridged by a methylene unit in an unprecedented way, and huncaniterine B (<b>3a</b>) is a pleiocarpamine–aspidofractinine-type dimer. The structures and relative configurations of these compounds were elucidated on the basis of NMR and MS analyses. Their absolute configurations were defined by means of experimental and calculated ECD data, and additionally, the structures of <b>5</b> and <b>13</b> were determined by single crystal X-ray diffraction. Compounds <b>1a</b>, <b>2</b>, <b>3b</b>, <b>4</b>, <b>6</b>, <b>9</b>, and <b>12</b> displayed cancer chemopreventive properties through either quinone reductase induction (<i>CD</i> = 30.7, 30.2, 29.9, 43.5, and 36.7 μM for <b>1a</b>, <b>4</b>, <b>6</b>, <b>9</b>, and <b>12</b>, respectively) and/or NF-κB inhibition with IC₅₀ values of 13.1, 8.4, 9.4, and 8.8 μM for <b>2</b>, <b>3b</b>, <b>6</b>, and <b>12</b>, respectively